Patents by Inventor Min-Gyu Soung

Min-Gyu Soung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250011364
    Abstract: The tumor tissue-penetrating peptide of the present invention, a derivative thereof, or a fragment thereof effectively delivers a drug deep into tumor or tissues through an assembling or fusion method and exhibits not only excellent penetration activity into biomembranes but also excellent tumor selectivity to maximize anticancer activity, and thus the tumor tissue-penetrating peptide, a derivative thereof, or a fragment thereof can be widely utilized as an active ingredient in pharmaceutical compositions for treatment or prevention of and compositions for diagnosis of cancer or angiogenesis-related diseases, which exhibit improved tumor selectivity and delivery ability to tumor and target cancer tissues or cells including biomembranes.
    Type: Application
    Filed: July 15, 2022
    Publication date: January 9, 2025
    Applicant: CELLICON LAB INC.
    Inventors: Min Gyu SOUNG, Bo Kyung PARK, Won Suk CHOI, Young Pil JEONG, Mi Yeong AN, Jae Hoo PARK
  • Patent number: 7687043
    Abstract: A heat block assembly and an organic compound synthesizing apparatus using the heat block assembly are provided. The heat block assembly includes one or more heat blocks provided with grooves in which reaction containers are inserted, and a temperature adjustor for adjusting the temperature of the heat block.
    Type: Grant
    Filed: June 15, 2007
    Date of Patent: March 30, 2010
    Assignee: Peptron Co., Ltd
    Inventors: Min-Gyu Soung, Jong-Il Park, Seung-Gu Chang, Ho-Il Choi, Heung-Jae Kim
  • Publication number: 20100021480
    Abstract: This invention relates to a technology of modifying low-molecular-weight bioactive substances with short in vivo half-life and low stability in order to achieve a stable and efficient in vivo delivery thereof. More specifically, the present invention relates to a stable bioactive substance-blood protein conjugate, wherein a low-molecular-weight bioactive substance is ex vivo conjugated with a specific functional group on a blood protein through a reactive group, the low-molecular-weight bioactive substance is available as a drug for treatment and prevention in mammals including human and selected from the group consisting of a natural substance; and a method of a stable and efficient in vivo delivery of the low-molecular-weight bioactive substance based on the use of the bioactive substance-blood protein conjugate.
    Type: Application
    Filed: October 27, 2006
    Publication date: January 28, 2010
    Applicant: PEPTRON CO., LTD
    Inventors: Jong-Il Park, Min-Gyu Soung, Heung-Jae Kim, Chae-Jin Lim, Jong-Phil Kang, Ho-Il Choi
  • Publication number: 20070292322
    Abstract: A heat block assembly and an organic compound synthesizing apparatus using the heat block assembly are provided. The heat block assembly includes one or more heat blocks provided with grooves in which reaction containers are inserted, and a temperature adjustor for adjusting the temperature of the heat block.
    Type: Application
    Filed: June 15, 2007
    Publication date: December 20, 2007
    Applicant: PEPTRON CO., LTD
    Inventors: Min-Gyu SOUNG, Jong-II Park, Seung-Gu Chang, Ho-II Choi, Heung-Jae Kim